Protalix BioTherapeutics Inc (PLX)

1.75 -0.01 (-0.57%) USD  |  NYAM  |  Dec 23, 16:00
1.75 0.00 (0.00%) After-Hours: 20:00
More

Protalix BioTherapeutics Cash and Short Term Investments (Quarterly): 27.41M for Sept. 30, 2024

Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for PLX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Cash and Short Term Investments Definition

View Cash and Short Term Investments Definition
Start Trial

Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Accuray Inc 59.21M
AIM ImmunoTech Inc 7.202M
Perspective Therapeutics Inc 267.85M
Electromed Inc 13.86M
Armata Pharmaceuticals Inc 17.14M